Impact of Body Weight on Pharmacokinetic Analysis of Doxorubicin + Cyclophosphamide in Breast Cancer
Status: WITHDRAWN
Study type: OBSERVATIONAL
Conditions: Breast Cancer
Sponsor: University of Texas Southwestern Medical Center
Collaborators: Texas Tech University Health Sciences Center